GI (Gastrointestinal)
A0022101 at https://clinicaltrials.gov/study/NCT05673148?term=NCT05673148&rank=1
NCT05673148
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASUR)
Cancer Type: Pathologically proven diagnosis of colorectal adenocarcinoma with metastases (biopsy from primary tumor or metastatic site is acceptable).
No known microsatellite instable (MSI) tumor.
No known BRAF V600E mutation.
Principal Investigator: Dr. Shanel Bhagwandin
Please contact Clinical Trials Office for more details: 561-263-5791
-
Jupiter Medical CenterWe want to help you! If you have questions about our services and what we can offer you and your loved ones, please reach out.
